Intervention targeting NAMPT has the potential to break the vicious cycle of SIRT1/NAMPT/NAD+/SIRT1 and reverse the clinical course of obesity induced OSA. The gene discussed is NAMPT; the disease is obstructive sleep apnea syndrome.